The p/tADC ratio reflects stromal and microenvironmental changes associated with tumor aggressiveness and may serve as a noninvasive imaging biomarker. Its integration into preoperative MRI protocols may facilitate risk stratification and personalized treatment planning.
Gündoğdu et al. (Thu,) studied this question.